Response to the West African Ebola outbreak and other global health emergencies by the World Health Organization (WHO) has been hampered by substantial budget cuts in recent years, The New York Times reported yesterday.
The man infected at least two other people, and officials again stressed urgent steps.
CDC director calls for immediate biodefense aid, and the FAO warns about Ebola-caused food shortages.
The US Department of Health and Human Services (HHS) will spend up to $42.3 million to help accelerate development of the experimental Ebola drug ZMapp, the agency said in a press release today.
With 29 new infections, the DRC outbreak has grown to 53 cases and 31 deaths.
Senegal announced today the country's first Ebola virus disease case, in a student from Guinea who was located in a Dakar hospital.
The National Institutes of Health (NIH) has partnered with an international-based consortium based in Britain to fast-forward work on an Ebola virus vaccine developed by GSK that has shown promise in nonhuman primate studies.
With an estimated price tag of $490 million, the plan's goal is to stop Ebola transmission in 6 to 9 months.
In addition, Canada pulled a lab team from Sierra Leone.
The US government plans to request that federally funded laboratories suspend all work on potentially dangerous pathogens for about 24 hours to inventory stocks of microbes, ScienceInsider reported today.
